Harbor Capital Advisors Inc. Decreases Stock Position in HealthEquity, Inc. $HQY

Harbor Capital Advisors Inc. decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 67.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,021 shares of the company’s stock after selling 32,610 shares during the period. Harbor Capital Advisors Inc.’s holdings in HealthEquity were worth $1,518,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Westfield Capital Management Co. LP grew its holdings in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of HealthEquity by 1.4% in the first quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company’s stock valued at $100,138,000 after purchasing an additional 15,458 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in HealthEquity by 2.6% in the second quarter. Charles Schwab Investment Management Inc. now owns 1,129,115 shares of the company’s stock worth $118,286,000 after purchasing an additional 28,145 shares during the last quarter. Geneva Capital Management LLC raised its stake in HealthEquity by 6.2% during the second quarter. Geneva Capital Management LLC now owns 1,108,241 shares of the company’s stock valued at $116,099,000 after purchasing an additional 64,487 shares in the last quarter. Finally, AQR Capital Management LLC lifted its position in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 17,240 shares of company stock worth $1,640,164 in the last 90 days. 1.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

HQY has been the topic of a number of research reports. Citizens Jmp boosted their target price on shares of HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a report on Thursday, December 4th. Barclays initiated coverage on HealthEquity in a research note on Monday, December 8th. They set an “overweight” rating and a $118.00 price objective on the stock. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Jefferies Financial Group boosted their target price on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $120.27.

HealthEquity Price Performance

Shares of HQY stock opened at $93.48 on Friday. The stock has a 50 day moving average price of $97.28 and a 200 day moving average price of $95.88. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The firm has a market capitalization of $7.99 billion, a P/E ratio of 42.88, a P/E/G ratio of 1.34 and a beta of 0.18.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter last year, the firm posted $0.78 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, sell-side analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.